Business

Proteomics locks in US patent for throat cancer test

December 17, 202556 views0

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.

Business / Companies

Brisbane Times – Business

Could AI help make our workplaces more inclusive?

For neurodivergent staff, AI tools are often the difference between coping and thriving, as long ...

1 day ago

Business

AI is eating software, and it’s cost Atlassian duo $34.6 billion

Investors have finally woken up to the risk that artificial intelligence won’t just kill white-collar ...

1 day ago

Business

For the first time in 50 years, uni graduates are losing their edge

For nearly half a century, research has shown that having a bachelor’s degree or higher ...

1 day ago

Now Reading

Proteomics locks in US patent for throat cancer test

1min read

0 %

Proteomics locks in US patent for throat cancer test

‘Job of a lifetime’: Australia’s biggest super fund hunts for new investment chief

Marmota wraps up drilling blitz at big new SA Gawler gold play

Leave a reply Cancel reply

More in:Business

Could AI help make our workplaces more inclusive?

AI is eating software, and it’s cost Atlassian duo $34.6 billion

For the first time in 50 years, uni graduates are losing their edge

Posts List

ASX Runners of the Week: Solstice, Alma Metals, RBR Group & First Au

Old Mexican core samples spark new bulk silver play for Advance

Flagship spots district-scale targets from space at Chilean gold play

Categories

The Inland Report

Share

You may also like

Leave a reply Cancel reply

More in:Business

Posts List

Categories

Latest Posts